TerminatedPhase 3NCT02266849

Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study

Studying Short bowel syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Odense University Hospital
Principal Investigator
Niels Qvist, MD, DMsc
Odense University Hospital, Department of Surgery A, Denmark
Intervention
Loperamide(drug)
Enrollment
12 enrolled
Eligibility
18 years · All sexes
Timeline
20142015

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02266849 on ClinicalTrials.gov

Other trials for Short bowel syndrome

Additional recruiting or active studies for the same condition.

See all trials for Short bowel syndrome

← Back to all trials